[Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13, 1–5, 2012.10.1111/j.1399-5448.2011.00777.x21545675]Search in Google Scholar
[Cartwright A, Wallymahmed M, Macfarlane IA, Wallymahmed A, Williams G, Gill GV. The outcome of brittle type 1 diabetes-a 20 year study. QJM 104, 575–579, 2011.10.1093/qjmed/hcr01021285231]Search in Google Scholar
[Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 45, 937–948, 2002.10.1007/s00125-002-0822-912136392]Search in Google Scholar
[Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245–1249, 2005.10.2337/diacare.28.5.124515855602]Search in Google Scholar
[Eisenbarth GS, Wilson PW, Ward F, Buckley C, Lebovita H. The polyglandular failure syndrome: disease inheritance, HLA type, and immune function. Ann Intern Med 91, 528–533, 1979.10.7326/0003-4819-91-4-528314765]Search in Google Scholar
[Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 25, 501–504, 2008.10.1111/j.1464-5491.2008.02413.x18387080]Search in Google Scholar
[IDF: IDF Diabetes Atlas. Eighth edition, 2017. Retrieved from http://www.diabetesatlas.org]Search in Google Scholar
[Krieger DT, Allen W, Rizzo F, Krieger HP. Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32, 266–284, 1971.10.1210/jcem-32-2-2664321505]Search in Google Scholar
[Laimer M, Melmer A, Mader JK, Schutz-Fuhrmann I, Engels HR, Gotz G, Pfeifer M, Hermann JM, Stettler C, Holl RW. Variability of basal rate profiles in insulin pump therapy and association with complications in type 1 diabetes mellitus. PLoS One 11, e0150604, 2016.10.1371/journal.pone.0150604477750326938444]Search in Google Scholar
[Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C, Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329, 977–986, 1993.10.1056/NEJM1993093032914018366922]Search in Google Scholar
[Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37, 9–16, 2014.10.2337/dc13-2112386799924356592]Search in Google Scholar
[Neufeld M, Blizzard R. Polyglandular autoimmune diseases. In A. Pinchera, D. Doniach, G. Fenzi, L. Baschieri (Eds.), Symposium on Autoimmune Aspects of Endocrine Disorders, pp. 357–365, New York, Academic Press, 1980.]Search in Google Scholar
[Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 31, 353–368, vi–vii, 2002.10.1016/S0889-8529(01)00015-9]Search in Google Scholar
[Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP, Ross RJ. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab 93, 2300–2306, 2008.10.1210/jc.2007-2674]Search in Google Scholar
[Samaan NA. Hypoglycemia secondary to endocrine deficiencies. Endocrinol Metab Clin North Am 18, 145–154, 1989.10.1016/S0889-8529(18)30393-1]Search in Google Scholar
[Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract 69, 14–21, 2005.10.1016/j.diabres.2004.11.00515955383]Search in Google Scholar
[Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384–1395, 2013.10.2337/dc12-2480363186723589542]Search in Google Scholar
[Shah JH, Motto GS, Papagiannes E, Williams GA. Insulin metabolism in hypothyroidism. Diabetes 24, 922–925, 1975.10.2337/diabetes.24.10.922]Search in Google Scholar
[Skordis N, Maclaren N. Chapter 15: Immunogenetics of autoimmune polyglandular syndromes. In N. Farid (Ed.), Immunogenetics of endocrine disorders, pp. 373–399, New York, Alan R. Liss, Inc., 1988.]Search in Google Scholar
[Sperling M, Yau M. Autoimmune Polyglandular Syndromes. In K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J. M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D. L. Trence, A. Vinik, & D. P. Wilson (Eds.), Endotext. South Dartmouth (MA): MDText.com, Inc., 2000.]Search in Google Scholar